SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-24-253250
Filing Date
2024-11-07
Accepted
2024-11-07 16:40:30
Documents
16
Period of Report
2024-11-07
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d848707d8k.htm   iXBRL 8-K 26589
2 EX-99.1 d848707dex991.htm EX-99.1 49680
7 GRAPHIC g848707g1108000707274.jpg GRAPHIC 2117
  Complete submission text file 0001193125-24-253250.txt   241003

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA etnb-20241107.xsd EX-101.SCH 3213
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE etnb-20241107_def.xml EX-101.DEF 13331
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE etnb-20241107_lab.xml EX-101.LAB 21786
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE etnb-20241107_pre.xml EX-101.PRE 14087
18 EXTRACTED XBRL INSTANCE DOCUMENT d848707d8k_htm.xml XML 5357
Mailing Address 142 SANSOME STREET SECOND FLOOR SAN FRANCISCO CA 94104
Business Address 142 SANSOME STREET SECOND FLOOR SAN FRANCISCO CA 94104 (415) 432-9270
89bio, Inc. (Filer) CIK: 0001785173 (see all company filings)

IRS No.: 831114349 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39122 | Film No.: 241436616
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)